GlobalData on MSN8h
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.
Pet owners report extreme alleged side effects from ‘miracle drug’ Librela for arthritic dogs
The Globe and Mail spoke with eight people whose pet’s health declined after taking Librela. Drugmaker Zoetis has responded ...
The Best Options for Online Weight Loss Prescriptions in 2024
The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.
Oakland clinic gets medical device maker to disclose risk of false blood-oxygen reading
The pulse oximeter, a device that measures the degree to which red blood cells are saturated with oxygen, is one of health ...